about
European guidance for the diagnosis and management of osteoporosis in postmenopausal womenImpact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatmentFactors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providersMedication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature.Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISAPatterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiariesAdoption of once-monthly oral bisphosphonates and the impact on adherence.Associations between the 2007 Medicare reimbursement reduction for bone mineral density testing and osteoporosis drug therapy patterns of female Medicare beneficiaries.Access to oral osteoporosis drugs among female Medicare Part D beneficiaries.Why do women reject bisphosphonates for osteoporosis? A videographic study.Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trialBone mineral density in residents of care facilities for the aged and effect of pharmacotherapy.Adherence to osteoporosis treatments: room for improvementA blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial.Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands.Adherence and occurrence of fractures after switching to once-monthly oral bisphophonatesAbandoned acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: a qualitative longitudinal study.Preference for hip protectors among older adults at high risk for osteoporotic fractures.Patient treatment preferences for osteoporosisPatient willingness to take teriparatide.Improving care of patients at-risk for osteoporosis: a randomized controlled trialPrevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fractureBisphosphonate prescribing, persistence and cumulative exposure in Ontario, CanadaThe Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with Osteoporosis.Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: A 12-month randomized, clinical trialCost-effectiveness of different screening strategies for osteoporosis in postmenopausal women."Test me and treat me"--attitudes to vitamin D deficiency and supplementation: a qualitative study.Correlates of use of antifracture therapy in older women with low bone mineral density.Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based AnalysisTeaching medication adherence in US colleges and schools of pharmacy.Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysisOsteoporosis medication profile preference: results from the PREFER-US studyMedication burden of Saudi Arabian women receiving antiresorptive therapyDenosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer PerspectiveObserving versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques.How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.Loss of treatment benefit due to low compliance with bisphosphonate therapy.Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women.
P2860
Q24612411-F3EBB3A0-8252-4444-9B0A-871EAE184BCFQ28731336-ED5E5F93-3E96-43F8-A2BE-08112B5F57D0Q28744535-40FB0164-7A9E-42BD-BF85-968E805938F1Q30611728-4DC1245B-FE6E-4FDB-8934-211AE00D6DCFQ30988951-83C4DD6C-1712-4826-AC28-3205CAD3E3DDQ33617272-A4028BFA-E4D0-4DBF-985A-8421D8EA1CCDQ33701964-7E293972-8AFB-451B-BC22-181582A00AEFQ33831291-A7B3643E-FBBB-43AC-8741-6CFB369FD74BQ33841382-04AA57BB-46C5-415D-8417-4D2D263556D1Q33886937-C4383FF5-D870-476A-86A0-C008464A28DDQ33914033-A7F45A2E-B9F2-4562-8E66-18B68BE62091Q33948822-9EA216C7-7D02-4DAE-95C9-8061069FFDFEQ34033742-1DEB64A1-EC4B-4982-8C76-99F9E70DE2ADQ34070998-80482DB4-5726-4571-83EE-AD985C4284F8Q34441060-2F5511A9-1B69-43BD-AC10-E8CE129173FEQ34774658-94E90F26-77D9-4B52-9EC7-09B2B4009A13Q34821660-7EC8E9CE-FDD5-4FFF-9B94-9FFA7F90D6E8Q35083239-1C8B2342-43A4-4DCC-AE18-C42586866010Q35098210-88795051-DD42-4FA5-9A05-9BF95745C772Q35112445-3C04AA93-7AE4-461E-9370-B55BB83B41FEQ35585790-FB4B835D-5A2E-4DC4-9013-37D9D5A99018Q35683269-07F08E96-5C14-4B2B-926C-FDF967CC37EAQ35728334-0737654F-594D-4DAC-9039-9AFC937FD1CBQ35751437-4320E77D-0BF1-4749-BD4D-5820BDAD4052Q35756451-4C59DBE2-AF5F-48F2-BA1B-475CCB5B5098Q35774970-E39859B2-C67F-480D-8A43-B35DB24B10F1Q35854611-1892C040-CEA8-4A82-BEB0-9C0226931BEEQ35868662-5526F5A8-6A64-486F-BAE0-29E6F54E38E1Q35884814-1EAF1C11-FAAA-43F8-8242-674C68AE5E59Q35901389-3BB12247-94F7-47D9-8D00-BB21397AB4D9Q36045845-F2E84071-AF7B-4E0B-9618-D08B63F4A660Q36066102-24AF17DF-E649-4D06-94EF-8E4DEF78DA91Q36073645-F7EBD905-5213-4743-A4CF-98442A46C036Q36088579-17F94C6F-058E-4576-8715-1B7EF4882C38Q36311638-E85F7267-AD09-4812-991A-700C3F7BCA98Q36400967-BEDEC5B1-E328-419B-8068-F729D4E92809Q36488716-F7830CC5-1E91-45B1-A6DB-42E021AAA520Q36492900-756491AB-0694-4E2B-9306-731A44BCDF9BQ36495575-C48D048A-7E52-4EFD-8D9E-9BAEFB818FE2Q36516518-C1A2DF1A-E40D-48D5-9090-100433CDB289
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Compliance with osteoporosis medications.
@en
Compliance with osteoporosis medications.
@nl
type
label
Compliance with osteoporosis medications.
@en
Compliance with osteoporosis medications.
@nl
prefLabel
Compliance with osteoporosis medications.
@en
Compliance with osteoporosis medications.
@nl
P2093
P1476
Compliance with osteoporosis medications.
@en
P2093
Daniel H Solomon
Jeffrey N Katz
Jennifer M Polinski
Jerry Avorn
Joel S Finkelstein
M Alan Brookhart
Marilyn Arnold
P304
P356
10.1001/ARCHINTE.165.20.2414
P407
P577
2005-11-01T00:00:00Z